Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology*; D000818:Animals; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D001564:Benzo(a)pyrene; D001571:Benzoflavones / Q000494:pharmacology*; D001580:Benzopyrenes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D010212:Papilloma / Q000139:chemically induced; D010704:Phorbols / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000139:chemically induced*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014212:Tretinoin / Q000008:administration & dosage / Q000494:pharmacology*
D001551:Benz(a)Anthracenes; D001571:Benzoflavones; D001580:Benzopyrenes; D005419:Flavonoids; D010704:Phorbols; D001564:Benzo(a)pyrene; D008748:Methylcholanthrene; D014212:Tretinoin; D015127:9,10-Dimethyl-1,2-benzanthracene; C011512:alpha-naphthoflavone; D009955:Ornithine Decarboxylase; D013755:Tetradecanoylphorbol Acetate